CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis

Abdullah A Tarique1, Peter D Sly2, Patrick G Holt3

  • 1Child Health Research Centre, The University of Queensland, Brisbane, Australia.

Abstract

Insights

Macrophages in cystic fibrosis (CF) lung disease show abnormal M2 activation due to faulty cystic fibrosis trans-membrane conductance regulator (CFTR) function, contributing to inflammation.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Cell Biology

Background:

  • The role of macrophages in cystic fibrosis (CF) lung disease is understudied.
  • Macrophages, particularly alternatively activated M2 macrophages, are hypothesized to be abnormal in CF.

Purpose of the Study:

  • To investigate the phenotype and function of M1 and M2 macrophages in adults and children with CF.
  • To determine if cystic fibrosis trans-membrane conductance regulator (CFTR) influences macrophage polarization and function.

Main Methods:

  • Blood samples were collected from CF patients (adults and children) during acute exacerbation and stable states.
  • Monocytes were differentiated into macrophages and polarized into M1 and M2 phenotypes ex-vivo.
  • Macrophage function was assessed and compared to healthy controls.

Main Results:

  • Macrophages from CF patients failed to polarize to the M2 phenotype in the absence of functional CFTR.
  • This M2 polarization failure is linked to a post-transcriptional defect in IL-13Rα1 production and expression.
  • M1 polarization remained unaffected by CFTR status.

Conclusions:

  • An imbalance in macrophage phenotypes and functions, dependent on CFTR, may contribute to heightened inflammation in CF lung disease.
  • Dysfunctional M2 macrophages could play a significant role in CF pathogenesis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
954
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
588
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K